GL1X · GenesisL1 explorer

UniProt Q2N0S6

Envelope glycoprotein gp120 (Q2N0S6)

Envelope glycoprotein gp120 (UniProt Q2N0S6): 202 experimental structures on GenesisL1, 15 ligands bound, 1,568 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q2N0S6
Protein
Envelope glycoprotein gp120
Experimental structures
202
Predicted models
0
Ligands
15
Pockets
1,568 · 95 records with a druggable one

Structures

202 records of Q2N0S6 in the MolNFT archive: 202 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3J5MCryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabselectron microscopyA, E, I——
3J5MCryo-EM structure of the BG505 SOSIP.664 HIV-1 env trimer with 3 PGV04 fabselectron microscopyA, E, I——
4NCOCrystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly…x-ray diffractionA, E, I——
4NCOCrystal structure of the BG505 sosip GP140 HIV-1 env trimer in complex with the broadly…x-ray diffractionA, E, I——
4ZMJCrystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimerx-ray diffractionG, B——
4ZMJCrystal structure of ligand-free BG505 SOSIP.664 HIV-1 env trimerx-ray diffractionG, B——
5ACOCryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimerelectron microscopyA, B, C, D, E, F——
5C7KCrystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies…x-ray diffractionC, D——
5C7KCrystal structure BG505 sosip GP140 HIV-1 env trimer bound to broadly neutralizing antibodies…x-ray diffractionC, D——
5CEZCrystal structure of the BG505 sosip GP140 HIV-1 env trimer in complex with an early putative…x-ray diffractionG, B——
5CJXCrystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 env trimerx-ray diffractionB, G, J, K, X, Y——
5D9QCrystal structure of the BG505 sosip GP140 HIV-1 env trimer in complex with the broadly…x-ray diffractionG, A, J——
5FYLCrystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion…x-ray diffractionB, GNAG, MAN, BMA—
5FYLCrystal structure at 3.7 a resolution of fully glycosylated HIV-1 clade a BG505 SOSIP.664 prefusion…x-ray diffractionB, G——
5I8HCrystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting…x-ray diffractionA, B, C, DNAG, MAN—
5I8HCrystal structure of HIV-1 BG505 SOSIP.664 prefusion env trimer in complex with V3 loop-targeting…x-ray diffractionA, B, C, D——
5T3SHIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022x-ray diffractionG, BNAG, BMA, MAN14 (best 0.63)
5T3SHIV GP140 trimer MD39-10MUTA in complex with fabs PGT124 and 35022x-ray diffractionG, BNAG, MAN—
5T3X3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env…x-ray diffractionB, GNAG, FUC, MAN8 (best 0.78)
5T3X3.9 ångström crystal structure of a fully and natively glycosylated BG505 SOSIP.664 HIV-1 env…x-ray diffractionB, GNAG, FUC, MAN—
5T3Z3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env…x-ray diffractionB, GNAG, FUC, MAN12 (best 0.78)
5T3Z3.5 ångström crystal structure of a fully and natively glycosylated BG505 SOSIP.664 HIV-1 env…x-ray diffractionB, GNAG, FUC, MAN—
5THRCryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complexelectron microscopyA, B, C, D, E, FNAG20 (best 0.82)
5THRCryo-EM structure of a BG505 env-SCD4-17B-8ANC195 complexelectron microscopyA, B, C, D, E, FNAG—
5U1FInitial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with…electron microscopyC, D, A, B, E, F——
5U1FInitial contact of HIV-1 env with CD4: cryo-EM structure of BG505 ds- sosip trimer in complex with…electron microscopyC, D, A, B, E, F——
5UTFCrystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations…x-ray diffractionG, BNAG, MAN11 (best 0.71)
5UTFCrystal structure of a stabilized ds-SOSIP.6MUT BG505 GP140 HIV-1 env trimer, containing mutations…x-ray diffractionG, BNAG, MAN—
5UTYCrystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations…x-ray diffractionB, GNAG, MAN9 (best 0.68)
5UTYCrystal structure of a stabilized ds-SOSIP.MUT4 BG505 GP140 HIV-1 env trimer, containing mutations…x-ray diffractionB, GNAG, MAN—
5V7JCrystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env…x-ray diffractionG, BNAG, MAN10 (best 0.79)
5V7JCrystal structure at 3.7 a resolution of glycosylated HIV-1 clade a BG505 SOSIP.664 prefusion env…x-ray diffractionG, BNAG, MAN—
5V8LBG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145electron microscopyA, B, C, D, E, FNAG, BMA, MAN20 (best 0.84)
5V8LBG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145electron microscopyA, B, C, D, E, FNAG, BMA, MAN—
5V8MBG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117electron microscopyA, B, F, I, G, JNAG, BMA, MAN20 (best 0.82)
5V8MBG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117electron microscopyA, B, F, I, G, JNAG, BMA—
5VIYBG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195electron microscopyA, B, C, D, E, FNAG, MAN, FUC18 (best 0.81)
5VIYBG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195electron microscopyA, B, C, D, E, FNAG, MAN—
5VJ6BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195electron microscopyA, B, C, D, E, F—15 (best 0.81)
5VJ6BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195electron microscopyA, B, C, D, E, F——
5W6DCrystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109Lx-ray diffractionBNAG—
5W6DCrystal structure of BG505-SOSIP.V4.1-GT1-N137A in complex with fabs 35022 and 9H/109Lx-ray diffractionBNAG—
5WDUHIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and…x-ray diffractionG, F, QNAG, MAN17 (best 0.80)
5WDUHIV-1 env BG505 SOSIP.664 H72C-H564C trimer in complex with bnabs PGT122 Fab, 35O22 Fab and…x-ray diffractionG, F, QNAG, MAN—
6B0NCrystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A…x-ray diffractionGNAG, MAN15 (best 0.76)
6B0NCrystal structure of the cleavage-independent prefusion HIV env glycoprotein trimer of the clade a…x-ray diffractionGNAG, MAN—
6CH7XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex…x-ray diffractionGNAG, FUC, MAN8 (best 0.76)
6CH7Xfel crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV- 1 envelope trimer in complex…x-ray diffractionGNAG, FUC, MAN—
6CH8Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with…x-ray diffractionGNAG, BMA, MAN5 (best 0.77)
6CH8Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 envelope trimer in complex with…x-ray diffractionGNAG, BMA, MAN—
6CHBCrystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with…x-ray diffractionG, F, H—17 (best 0.84)
6CHBCrystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 envelope trimer in complex with…x-ray diffractionG, F, H——
6CUECryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1…electron microscopyc, 2, CNAG19 (best 0.82)
6CUFCryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1…electron microscopyC, 2, dNAG, MAN20 (best 0.84)
6DE7Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env…x-ray diffractionGNAG, MAN, SO412 (best 0.71)
6DE7Crystal structure at 4.3 a resolution of glycosylated HIV-1 clade a BG505 SOSIP.664 prefusion env…x-ray diffractionGNAG, MAN, SO4—
6DFGBG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen bindingelectron microscopyA, C, DNAG, MAN20 (best 0.78)
6DFGBG505 MD39 sosip trimer in complex with mature BG18 fragment antigen bindingelectron microscopyA, C, DNAG, MAN—
6DFHBG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen bindingelectron microscopyA, C, DNAG, MAN19 (best 0.85)
6DFHBG505 MD64 N332-GT2 sosip trimer in complex with germline-reverted BG18 fragment antigen bindingelectron microscopyA, C, DNAG, MAN—

142 records more on the page itself.

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 178 records
  • MAN · alpha-D-mannopyranose · in 120 records
  • BMA · beta-D-mannopyranose · in 30 records
  • FUC · alpha-L-fucopyranose · in 17 records
  • 5VG · ~{N}'-[(1~{R},2~{R})-2-(carbamimidamidomethyl)-5-(methylaminomethyl)-2,3-dihydro-1~{H}-inden-1-yl]-~{N}-(4-chloranyl-3-fluoranyl-phenyl)ethanediamide · in 2 records
  • 83G · 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione · in 2 records
  • JYJ · {4-[1-(3-chlorophenyl)cyclopropane-1-carbonyl]piperazin-1-yl}(thiophen-3-yl)methanone · in 2 records
  • JYS · 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-(4-bromo-7-fluoro-1H-indol-3-yl)ethane-1,2-dione · in 2 records
  • JYV · (2R)-{1-[{7-[2-({[3-(dimethylamino)propyl](methyl) amino}methyl)-1,3-thiazol-4-yl]-4-methoxy-1H-pyrrolo[2,3-c]pyridin-3-yl}(oxo)acetyl]piperidin-4-yl}(phenyl)acetonitrile · in 2 records
  • JYY · 4-{3-[{4-[(R)-cyano(phenyl)methyl]piperidin-1-yl}(oxo) acetyl]-4-methoxy-1H-pyrrolo[2,3-c]pyridin-7-yl}-N-(2-hydroxyethyl)-1,3-thiazole-2-carboxamide · in 2 records
  • SO4 · Sulfate ion · in 2 records
  • 83J · 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2-dione · in 1 record
  • MPT · Beta-mercaptopropionic acid · in 1 record
  • NH2 · Amino group · in 1 record
  • PO4 · Phosphate ion · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.